Reuters logo
BRIEF-Aurinia reports Q3 loss per share $0.16
November 14, 2017 / 9:15 PM / a month ago

BRIEF-Aurinia reports Q3 loss per share $0.16

Nov 14 (Reuters) - Aurinia Pharmaceuticals Inc

* Aurinia reports third quarter 2017 financial results and provides operational highlights

* Aurinia Pharmaceuticals Inc - ‍Aurora phase III trial in lupus nephritis on track​

* Q3 loss per share $0.16

* Aurinia Pharmaceuticals - Believe​ co have sufficient financial resources to fund LN program,conduct work on new indications & fund operations into 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below